Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Cancer Ablation Devices Market Growth 2022-2028

  • LP 4858269
  • 119 Pages
  • February 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Cancer Ablation Devices will have significant change from previous year. According to our (LP Information) latest study, the global Cancer Ablation Devices market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Cancer Ablation Devices market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Cancer Ablation Devices market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cancer Ablation Devices market, reaching US$ million by the year 2028. As for the Europe Cancer Ablation Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Cancer Ablation Devices players cover Alfresa Pharma Corp., AngioDynamics, Inc., BTG plc (Galil Medical Ltd./Perseon Medical), and Biomedical S.r.l., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Ablation Devices market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Cryoablation

High-Intensity Focused Ultrasound (HIFU)

Laser Interstitial Thermal Therapy (LiTT)

Microwave Ablation (MWA)

Radiofrequency Ablation (RFA)

Irreversible Electroporation (Ire)

Non-Thermal Ablation

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Brain Cancer

Brown

Colorectal Cancer

Kidney Cancer

Liver Cancer

Lung Cancer

Pancreatic Cancer

Prostate Cancer

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Alfresa Pharma Corp.

AngioDynamics, Inc.

BTG plc (Galil Medical Ltd./Perseon Medical)

Biomedical S.r.l.

Boston Scientific Corporation

CSA Medical, Inc.

Chongqing Haifu Medical Technology Co., Ltd

ECO Medical

EDAP TMS S.A.

HS Hospital Service S.p.A.

IceCure Medical, Inc.

Johnson & Johnson (Ethicon, Inc.)

Kang-Yu Medical Co., Ltd.

MedLink Technologies LLC

MedWaves, Inc.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cancer Ablation Devices Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Cancer Ablation Devices by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Cancer Ablation Devices by Country/Region, 2017, 2022 & 2028

2.2 Cancer Ablation Devices Segment by Type

2.2.1 Cryoablation

2.2.2 High-Intensity Focused Ultrasound (HIFU)

2.2.3 Laser Interstitial Thermal Therapy (LiTT)

2.2.4 Microwave Ablation (MWA)

2.2.5 Radiofrequency Ablation (RFA)

2.2.6 Irreversible Electroporation (Ire)

2.2.7 Non-Thermal Ablation

2.3 Cancer Ablation Devices Sales by Type

2.3.1 Global Cancer Ablation Devices Sales Market Share by Type (2017-2022)

2.3.2 Global Cancer Ablation Devices Revenue and Market Share by Type (2017-2022)

2.3.3 Global Cancer Ablation Devices Sale Price by Type (2017-2022)

2.4 Cancer Ablation Devices Segment by Application

2.4.1 Brain Cancer

2.4.2 Brown

2.4.3 Colorectal Cancer

2.4.4 Kidney Cancer

2.4.5 Liver Cancer

2.4.6 Lung Cancer

2.4.7 Pancreatic Cancer

2.4.8 Prostate Cancer

2.5 Cancer Ablation Devices Sales by Application

2.5.1 Global Cancer Ablation Devices Sale Market Share by Application (2017-2022)

2.5.2 Global Cancer Ablation Devices Revenue and Market Share by Application (2017-2022)

2.5.3 Global Cancer Ablation Devices Sale Price by Application (2017-2022)

3 Global Cancer Ablation Devices by Company

3.1 Global Cancer Ablation Devices Breakdown Data by Company

3.1.1 Global Cancer Ablation Devices Annual Sales by Company (2020-2022)

3.1.2 Global Cancer Ablation Devices Sales Market Share by Company (2020-2022)

3.2 Global Cancer Ablation Devices Annual Revenue by Company (2020-2022)

3.2.1 Global Cancer Ablation Devices Revenue by Company (2020-2022)

3.2.2 Global Cancer Ablation Devices Revenue Market Share by Company (2020-2022)

3.3 Global Cancer Ablation Devices Sale Price by Company

3.4 Key Manufacturers Cancer Ablation Devices Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Cancer Ablation Devices Product Location Distribution

3.4.2 Players Cancer Ablation Devices Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Cancer Ablation Devices by Geographic Region

4.1 World Historic Cancer Ablation Devices Market Size by Geographic Region (2017-2022)

4.1.1 Global Cancer Ablation Devices Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Cancer Ablation Devices Annual Revenue by Geographic Region

4.2 World Historic Cancer Ablation Devices Market Size by Country/Region (2017-2022)

4.2.1 Global Cancer Ablation Devices Annual Sales by Country/Region (2017-2022)

4.2.2 Global Cancer Ablation Devices Annual Revenue by Country/Region

4.3 Americas Cancer Ablation Devices Sales Growth

4.4 APAC Cancer Ablation Devices Sales Growth

4.5 Europe Cancer Ablation Devices Sales Growth

4.6 Middle East & Africa Cancer Ablation Devices Sales Growth

5 Americas

5.1 Americas Cancer Ablation Devices Sales by Country

5.1.1 Americas Cancer Ablation Devices Sales by Country (2017-2022)

5.1.2 Americas Cancer Ablation Devices Revenue by Country (2017-2022)

5.2 Americas Cancer Ablation Devices Sales by Type

5.3 Americas Cancer Ablation Devices Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cancer Ablation Devices Sales by Region

6.1.1 APAC Cancer Ablation Devices Sales by Region (2017-2022)

6.1.2 APAC Cancer Ablation Devices Revenue by Region (2017-2022)

6.2 APAC Cancer Ablation Devices Sales by Type

6.3 APAC Cancer Ablation Devices Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Cancer Ablation Devices by Country

7.1.1 Europe Cancer Ablation Devices Sales by Country (2017-2022)

7.1.2 Europe Cancer Ablation Devices Revenue by Country (2017-2022)

7.2 Europe Cancer Ablation Devices Sales by Type

7.3 Europe Cancer Ablation Devices Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cancer Ablation Devices by Country

8.1.1 Middle East & Africa Cancer Ablation Devices Sales by Country (2017-2022)

8.1.2 Middle East & Africa Cancer Ablation Devices Revenue by Country (2017-2022)

8.2 Middle East & Africa Cancer Ablation Devices Sales by Type

8.3 Middle East & Africa Cancer Ablation Devices Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Cancer Ablation Devices

10.3 Manufacturing Process Analysis of Cancer Ablation Devices

10.4 Industry Chain Structure of Cancer Ablation Devices

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Cancer Ablation Devices Distributors

11.3 Cancer Ablation Devices Customer

12 World Forecast Review for Cancer Ablation Devices by Geographic Region

12.1 Global Cancer Ablation Devices Market Size Forecast by Region

12.1.1 Global Cancer Ablation Devices Forecast by Region (2023-2028)

12.1.2 Global Cancer Ablation Devices Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Cancer Ablation Devices Forecast by Type

12.7 Global Cancer Ablation Devices Forecast by Application

13 Key Players Analysis

13.1 Alfresa Pharma Corp.

13.1.1 Alfresa Pharma Corp. Company Information

13.1.2 Alfresa Pharma Corp. Cancer Ablation Devices Product Offered

13.1.3 Alfresa Pharma Corp. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Alfresa Pharma Corp. Main Business Overview

13.1.5 Alfresa Pharma Corp. Latest Developments

13.2 AngioDynamics, Inc.

13.2.1 AngioDynamics, Inc. Company Information

13.2.2 AngioDynamics, Inc. Cancer Ablation Devices Product Offered

13.2.3 AngioDynamics, Inc. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AngioDynamics, Inc. Main Business Overview

13.2.5 AngioDynamics, Inc. Latest Developments

13.3 BTG plc (Galil Medical Ltd./Perseon Medical)

13.3.1 BTG plc (Galil Medical Ltd./Perseon Medical) Company Information

13.3.2 BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Product Offered

13.3.3 BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 BTG plc (Galil Medical Ltd./Perseon Medical) Main Business Overview

13.3.5 BTG plc (Galil Medical Ltd./Perseon Medical) Latest Developments

13.4 Biomedical S.r.l.

13.4.1 Biomedical S.r.l. Company Information

13.4.2 Biomedical S.r.l. Cancer Ablation Devices Product Offered

13.4.3 Biomedical S.r.l. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Biomedical S.r.l. Main Business Overview

13.4.5 Biomedical S.r.l. Latest Developments

13.5 Boston Scientific Corporation

13.5.1 Boston Scientific Corporation Company Information

13.5.2 Boston Scientific Corporation Cancer Ablation Devices Product Offered

13.5.3 Boston Scientific Corporation Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Boston Scientific Corporation Main Business Overview

13.5.5 Boston Scientific Corporation Latest Developments

13.6 CSA Medical, Inc.

13.6.1 CSA Medical, Inc. Company Information

13.6.2 CSA Medical, Inc. Cancer Ablation Devices Product Offered

13.6.3 CSA Medical, Inc. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 CSA Medical, Inc. Main Business Overview

13.6.5 CSA Medical, Inc. Latest Developments

13.7 Chongqing Haifu Medical Technology Co., Ltd

13.7.1 Chongqing Haifu Medical Technology Co., Ltd Company Information

13.7.2 Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Product Offered

13.7.3 Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Chongqing Haifu Medical Technology Co., Ltd Main Business Overview

13.7.5 Chongqing Haifu Medical Technology Co., Ltd Latest Developments

13.8 ECO Medical

13.8.1 ECO Medical Company Information

13.8.2 ECO Medical Cancer Ablation Devices Product Offered

13.8.3 ECO Medical Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 ECO Medical Main Business Overview

13.8.5 ECO Medical Latest Developments

13.9 EDAP TMS S.A.

13.9.1 EDAP TMS S.A. Company Information

13.9.2 EDAP TMS S.A. Cancer Ablation Devices Product Offered

13.9.3 EDAP TMS S.A. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 EDAP TMS S.A. Main Business Overview

13.9.5 EDAP TMS S.A. Latest Developments

13.10 HS Hospital Service S.p.A.

13.10.1 HS Hospital Service S.p.A. Company Information

13.10.2 HS Hospital Service S.p.A. Cancer Ablation Devices Product Offered

13.10.3 HS Hospital Service S.p.A. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 HS Hospital Service S.p.A. Main Business Overview

13.10.5 HS Hospital Service S.p.A. Latest Developments

13.11 IceCure Medical, Inc.

13.11.1 IceCure Medical, Inc. Company Information

13.11.2 IceCure Medical, Inc. Cancer Ablation Devices Product Offered

13.11.3 IceCure Medical, Inc. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 IceCure Medical, Inc. Main Business Overview

13.11.5 IceCure Medical, Inc. Latest Developments

13.12 Johnson & Johnson (Ethicon, Inc.)

13.12.1 Johnson & Johnson (Ethicon, Inc.) Company Information

13.12.2 Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Product Offered

13.12.3 Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Johnson & Johnson (Ethicon, Inc.) Main Business Overview

13.12.5 Johnson & Johnson (Ethicon, Inc.) Latest Developments

13.13 Kang-Yu Medical Co., Ltd.

13.13.1 Kang-Yu Medical Co., Ltd. Company Information

13.13.2 Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Product Offered

13.13.3 Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Kang-Yu Medical Co., Ltd. Main Business Overview

13.13.5 Kang-Yu Medical Co., Ltd. Latest Developments

13.14 MedLink Technologies LLC

13.14.1 MedLink Technologies LLC Company Information

13.14.2 MedLink Technologies LLC Cancer Ablation Devices Product Offered

13.14.3 MedLink Technologies LLC Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 MedLink Technologies LLC Main Business Overview

13.14.5 MedLink Technologies LLC Latest Developments

13.15 MedWaves, Inc.

13.15.1 MedWaves, Inc. Company Information

13.15.2 MedWaves, Inc. Cancer Ablation Devices Product Offered

13.15.3 MedWaves, Inc. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 MedWaves, Inc. Main Business Overview

13.15.5 MedWaves, Inc. Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Cancer Ablation Devices Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Cancer Ablation Devices Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Cryoablation

Table 4. Major Players of High-Intensity Focused Ultrasound (HIFU)

Table 5. Major Players of Laser Interstitial Thermal Therapy (LiTT)

Table 6. Major Players of Microwave Ablation (MWA)

Table 7. Major Players of Radiofrequency Ablation (RFA)

Table 8. Major Players of Irreversible Electroporation (Ire)

Table 9. Major Players of Non-Thermal Ablation

Table 10. Global Cancer Ablation Devices Sales by Type (2017-2022) & (K Units)

Table 11. Global Cancer Ablation Devices Sales Market Share by Type (2017-2022)

Table 12. Global Cancer Ablation Devices Revenue by Type (2017-2022) & ($ million)

Table 13. Global Cancer Ablation Devices Revenue Market Share by Type (2017-2022)

Table 14. Global Cancer Ablation Devices Sale Price by Type (2017-2022) & (US$/Unit)

Table 15. Global Cancer Ablation Devices Sales by Application (2017-2022) & (K Units)

Table 16. Global Cancer Ablation Devices Sales Market Share by Application (2017-2022)

Table 17. Global Cancer Ablation Devices Revenue by Application (2017-2022)

Table 18. Global Cancer Ablation Devices Revenue Market Share by Application (2017-2022)

Table 19. Global Cancer Ablation Devices Sale Price by Application (2017-2022) & (US$/Unit)

Table 20. Global Cancer Ablation Devices Sales by Company (2020-2022) & (K Units)

Table 21. Global Cancer Ablation Devices Sales Market Share by Company (2020-2022)

Table 22. Global Cancer Ablation Devices Revenue by Company (2020-2022) ($ Millions)

Table 23. Global Cancer Ablation Devices Revenue Market Share by Company (2020-2022)

Table 24. Global Cancer Ablation Devices Sale Price by Company (2020-2022) & (US$/Unit)

Table 25. Key Manufacturers Cancer Ablation Devices Producing Area Distribution and Sales Area

Table 26. Players Cancer Ablation Devices Products Offered

Table 27. Cancer Ablation Devices Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 28. New Products and Potential Entrants

Table 29. Mergers & Acquisitions, Expansion

Table 30. Global Cancer Ablation Devices Sales by Geographic Region (2017-2022) & (K Units)

Table 31. Global Cancer Ablation Devices Sales Market Share Geographic Region (2017-2022)

Table 32. Global Cancer Ablation Devices Revenue by Geographic Region (2017-2022) & ($ millions)

Table 33. Global Cancer Ablation Devices Revenue Market Share by Geographic Region (2017-2022)

Table 34. Global Cancer Ablation Devices Sales by Country/Region (2017-2022) & (K Units)

Table 35. Global Cancer Ablation Devices Sales Market Share by Country/Region (2017-2022)

Table 36. Global Cancer Ablation Devices Revenue by Country/Region (2017-2022) & ($ millions)

Table 37. Global Cancer Ablation Devices Revenue Market Share by Country/Region (2017-2022)

Table 38. Americas Cancer Ablation Devices Sales by Country (2017-2022) & (K Units)

Table 39. Americas Cancer Ablation Devices Sales Market Share by Country (2017-2022)

Table 40. Americas Cancer Ablation Devices Revenue by Country (2017-2022) & ($ Millions)

Table 41. Americas Cancer Ablation Devices Revenue Market Share by Country (2017-2022)

Table 42. Americas Cancer Ablation Devices Sales by Type (2017-2022) & (K Units)

Table 43. Americas Cancer Ablation Devices Sales Market Share by Type (2017-2022)

Table 44. Americas Cancer Ablation Devices Sales by Application (2017-2022) & (K Units)

Table 45. Americas Cancer Ablation Devices Sales Market Share by Application (2017-2022)

Table 46. APAC Cancer Ablation Devices Sales by Region (2017-2022) & (K Units)

Table 47. APAC Cancer Ablation Devices Sales Market Share by Region (2017-2022)

Table 48. APAC Cancer Ablation Devices Revenue by Region (2017-2022) & ($ Millions)

Table 49. APAC Cancer Ablation Devices Revenue Market Share by Region (2017-2022)

Table 50. APAC Cancer Ablation Devices Sales by Type (2017-2022) & (K Units)

Table 51. APAC Cancer Ablation Devices Sales Market Share by Type (2017-2022)

Table 52. APAC Cancer Ablation Devices Sales by Application (2017-2022) & (K Units)

Table 53. APAC Cancer Ablation Devices Sales Market Share by Application (2017-2022)

Table 54. Europe Cancer Ablation Devices Sales by Country (2017-2022) & (K Units)

Table 55. Europe Cancer Ablation Devices Sales Market Share by Country (2017-2022)

Table 56. Europe Cancer Ablation Devices Revenue by Country (2017-2022) & ($ Millions)

Table 57. Europe Cancer Ablation Devices Revenue Market Share by Country (2017-2022)

Table 58. Europe Cancer Ablation Devices Sales by Type (2017-2022) & (K Units)

Table 59. Europe Cancer Ablation Devices Sales Market Share by Type (2017-2022)

Table 60. Europe Cancer Ablation Devices Sales by Application (2017-2022) & (K Units)

Table 61. Europe Cancer Ablation Devices Sales Market Share by Application (2017-2022)

Table 62. Middle East & Africa Cancer Ablation Devices Sales by Country (2017-2022) & (K Units)

Table 63. Middle East & Africa Cancer Ablation Devices Sales Market Share by Country (2017-2022)

Table 64. Middle East & Africa Cancer Ablation Devices Revenue by Country (2017-2022) & ($ Millions)

Table 65. Middle East & Africa Cancer Ablation Devices Revenue Market Share by Country (2017-2022)

Table 66. Middle East & Africa Cancer Ablation Devices Sales by Type (2017-2022) & (K Units)

Table 67. Middle East & Africa Cancer Ablation Devices Sales Market Share by Type (2017-2022)

Table 68. Middle East & Africa Cancer Ablation Devices Sales by Application (2017-2022) & (K Units)

Table 69. Middle East & Africa Cancer Ablation Devices Sales Market Share by Application (2017-2022)

Table 70. Key Market Drivers & Growth Opportunities of Cancer Ablation Devices

Table 71. Key Market Challenges & Risks of Cancer Ablation Devices

Table 72. Key Industry Trends of Cancer Ablation Devices

Table 73. Cancer Ablation Devices Raw Material

Table 74. Key Suppliers of Raw Materials

Table 75. Cancer Ablation Devices Distributors List

Table 76. Cancer Ablation Devices Customer List

Table 77. Global Cancer Ablation Devices Sales Forecast by Region (2023-2028) & (K Units)

Table 78. Global Cancer Ablation Devices Sales Market Forecast by Region

Table 79. Global Cancer Ablation Devices Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Global Cancer Ablation Devices Revenue Market Share Forecast by Region (2023-2028)

Table 81. Americas Cancer Ablation Devices Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Americas Cancer Ablation Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. APAC Cancer Ablation Devices Sales Forecast by Region (2023-2028) & (K Units)

Table 84. APAC Cancer Ablation Devices Revenue Forecast by Region (2023-2028) & ($ millions)

Table 85. Europe Cancer Ablation Devices Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Europe Cancer Ablation Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Middle East & Africa Cancer Ablation Devices Sales Forecast by Country (2023-2028) & (K Units)

Table 88. Middle East & Africa Cancer Ablation Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 89. Global Cancer Ablation Devices Sales Forecast by Type (2023-2028) & (K Units)

Table 90. Global Cancer Ablation Devices Sales Market Share Forecast by Type (2023-2028)

Table 91. Global Cancer Ablation Devices Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 92. Global Cancer Ablation Devices Revenue Market Share Forecast by Type (2023-2028)

Table 93. Global Cancer Ablation Devices Sales Forecast by Application (2023-2028) & (K Units)

Table 94. Global Cancer Ablation Devices Sales Market Share Forecast by Application (2023-2028)

Table 95. Global Cancer Ablation Devices Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 96. Global Cancer Ablation Devices Revenue Market Share Forecast by Application (2023-2028)

Table 97. Alfresa Pharma Corp. Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 98. Alfresa Pharma Corp. Cancer Ablation Devices Product Offered

Table 99. Alfresa Pharma Corp. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Alfresa Pharma Corp. Main Business

Table 101. Alfresa Pharma Corp. Latest Developments

Table 102. AngioDynamics, Inc. Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 103. AngioDynamics, Inc. Cancer Ablation Devices Product Offered

Table 104. AngioDynamics, Inc. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. AngioDynamics, Inc. Main Business

Table 106. AngioDynamics, Inc. Latest Developments

Table 107. BTG plc (Galil Medical Ltd./Perseon Medical) Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 108. BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Product Offered

Table 109. BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. BTG plc (Galil Medical Ltd./Perseon Medical) Main Business

Table 111. BTG plc (Galil Medical Ltd./Perseon Medical) Latest Developments

Table 112. Biomedical S.r.l. Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 113. Biomedical S.r.l. Cancer Ablation Devices Product Offered

Table 114. Biomedical S.r.l. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Biomedical S.r.l. Main Business

Table 116. Biomedical S.r.l. Latest Developments

Table 117. Boston Scientific Corporation Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 118. Boston Scientific Corporation Cancer Ablation Devices Product Offered

Table 119. Boston Scientific Corporation Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Boston Scientific Corporation Main Business

Table 121. Boston Scientific Corporation Latest Developments

Table 122. CSA Medical, Inc. Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 123. CSA Medical, Inc. Cancer Ablation Devices Product Offered

Table 124. CSA Medical, Inc. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. CSA Medical, Inc. Main Business

Table 126. CSA Medical, Inc. Latest Developments

Table 127. Chongqing Haifu Medical Technology Co., Ltd Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 128. Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Product Offered

Table 129. Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Chongqing Haifu Medical Technology Co., Ltd Main Business

Table 131. Chongqing Haifu Medical Technology Co., Ltd Latest Developments

Table 132. ECO Medical Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 133. ECO Medical Cancer Ablation Devices Product Offered

Table 134. ECO Medical Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. ECO Medical Main Business

Table 136. ECO Medical Latest Developments

Table 137. EDAP TMS S.A. Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 138. EDAP TMS S.A. Cancer Ablation Devices Product Offered

Table 139. EDAP TMS S.A. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. EDAP TMS S.A. Main Business

Table 141. EDAP TMS S.A. Latest Developments

Table 142. HS Hospital Service S.p.A. Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 143. HS Hospital Service S.p.A. Cancer Ablation Devices Product Offered

Table 144. HS Hospital Service S.p.A. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. HS Hospital Service S.p.A. Main Business

Table 146. HS Hospital Service S.p.A. Latest Developments

Table 147. IceCure Medical, Inc. Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 148. IceCure Medical, Inc. Cancer Ablation Devices Product Offered

Table 149. IceCure Medical, Inc. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. IceCure Medical, Inc. Main Business

Table 151. IceCure Medical, Inc. Latest Developments

Table 152. Johnson & Johnson (Ethicon, Inc.) Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 153. Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Product Offered

Table 154. Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 155. Johnson & Johnson (Ethicon, Inc.) Main Business

Table 156. Johnson & Johnson (Ethicon, Inc.) Latest Developments

Table 157. Kang-Yu Medical Co., Ltd. Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 158. Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Product Offered

Table 159. Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 160. Kang-Yu Medical Co., Ltd. Main Business

Table 161. Kang-Yu Medical Co., Ltd. Latest Developments

Table 162. MedLink Technologies LLC Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 163. MedLink Technologies LLC Cancer Ablation Devices Product Offered

Table 164. MedLink Technologies LLC Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 165. MedLink Technologies LLC Main Business

Table 166. MedLink Technologies LLC Latest Developments

Table 167. MedWaves, Inc. Basic Information, Cancer Ablation Devices Manufacturing Base, Sales Area and Its Competitors

Table 168. MedWaves, Inc. Cancer Ablation Devices Product Offered

Table 169. MedWaves, Inc. Cancer Ablation Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 170. MedWaves, Inc. Main Business

Table 171. MedWaves, Inc. Latest Developments

List of Figures

Figure 1. Picture of Cancer Ablation Devices

Figure 2. Cancer Ablation Devices Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Cancer Ablation Devices Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Cancer Ablation Devices Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Cancer Ablation Devices Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Cryoablation

Figure 10. Product Picture of High-Intensity Focused Ultrasound (HIFU)

Figure 11. Product Picture of Laser Interstitial Thermal Therapy (LiTT)

Figure 12. Product Picture of Microwave Ablation (MWA)

Figure 13. Product Picture of Radiofrequency Ablation (RFA)

Figure 14. Product Picture of Irreversible Electroporation (Ire)

Figure 15. Product Picture of Non-Thermal Ablation

Figure 16. Global Cancer Ablation Devices Sales Market Share by Type in 2021

Figure 17. Global Cancer Ablation Devices Revenue Market Share by Type (2017-2022)

Figure 18. Cancer Ablation Devices Consumed in Brain Cancer

Figure 19. Global Cancer Ablation Devices Market: Brain Cancer (2017-2022) & (K Units)

Figure 20. Cancer Ablation Devices Consumed in Brown

Figure 21. Global Cancer Ablation Devices Market: Brown (2017-2022) & (K Units)

Figure 22. Cancer Ablation Devices Consumed in Colorectal Cancer

Figure 23. Global Cancer Ablation Devices Market: Colorectal Cancer (2017-2022) & (K Units)

Figure 24. Cancer Ablation Devices Consumed in Kidney Cancer

Figure 25. Global Cancer Ablation Devices Market: Kidney Cancer (2017-2022) & (K Units)

Figure 26. Cancer Ablation Devices Consumed in Liver Cancer

Figure 27. Global Cancer Ablation Devices Market: Liver Cancer (2017-2022) & (K Units)

Figure 28. Cancer Ablation Devices Consumed in Lung Cancer

Figure 29. Global Cancer Ablation Devices Market: Lung Cancer (2017-2022) & (K Units)

Figure 30. Cancer Ablation Devices Consumed in Pancreatic Cancer

Figure 31. Global Cancer Ablation Devices Market: Pancreatic Cancer (2017-2022) & (K Units)

Figure 32. Cancer Ablation Devices Consumed in Prostate Cancer

Figure 33. Global Cancer Ablation Devices Market: Prostate Cancer (2017-2022) & (K Units)

Figure 34. Global Cancer Ablation Devices Sales Market Share by Application (2017-2022)

Figure 35. Global Cancer Ablation Devices Revenue Market Share by Application in 2021

Figure 36. Cancer Ablation Devices Revenue Market by Company in 2021 ($ Million)

Figure 37. Global Cancer Ablation Devices Revenue Market Share by Company in 2021

Figure 38. Global Cancer Ablation Devices Sales Market Share by Geographic Region (2017-2022)

Figure 39. Global Cancer Ablation Devices Revenue Market Share by Geographic Region in 2021

Figure 40. Global Cancer Ablation Devices Sales Market Share by Region (2017-2022)

Figure 41. Global Cancer Ablation Devices Revenue Market Share by Country/Region in 2021

Figure 42. Americas Cancer Ablation Devices Sales 2017-2022 (K Units)

Figure 43. Americas Cancer Ablation Devices Revenue 2017-2022 ($ Millions)

Figure 44. APAC Cancer Ablation Devices Sales 2017-2022 (K Units)

Figure 45. APAC Cancer Ablation Devices Revenue 2017-2022 ($ Millions)

Figure 46. Europe Cancer Ablation Devices Sales 2017-2022 (K Units)

Figure 47. Europe Cancer Ablation Devices Revenue 2017-2022 ($ Millions)

Figure 48. Middle East & Africa Cancer Ablation Devices Sales 2017-2022 (K Units)

Figure 49. Middle East & Africa Cancer Ablation Devices Revenue 2017-2022 ($ Millions)

Figure 50. Americas Cancer Ablation Devices Sales Market Share by Country in 2021

Figure 51. Americas Cancer Ablation Devices Revenue Market Share by Country in 2021

Figure 52. United States Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)

Figure 53. Canada Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)

Figure 54. Mexico Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)

Figure 55. Brazil Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)

Figure 56. APAC Cancer Ablation Devices Sales Market Share by Region in 2021

Figure 57. APAC Cancer Ablation Devices Revenue Market Share by Regions in 2021

Figure 58. China Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)

Figure 59. Japan Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Korea Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)

Figure 61. Southeast Asia Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)

Figure 62. India Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)

Figure 63. Australia Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)

Figure 64. Europe Cancer Ablation Devices Sales Market Share by Country in 2021

Figure 65. Europe Cancer Ablation Devices Revenue Market Share by Country in 2021

Figure 66. Germany Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)

Figure 67. France Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)

Figure 68. UK Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)

Figure 69. Italy Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)

Figure 70. Russia Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)

Figure 71. Middle East & Africa Cancer Ablation Devices Sales Market Share by Country in 2021

Figure 72. Middle East & Africa Cancer Ablation Devices Revenue Market Share by Country in 2021

Figure 73. Egypt Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)

Figure 74. South Africa Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)

Figure 75. Israel Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)

Figure 76. Turkey Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)

Figure 77. GCC Country Cancer Ablation Devices Revenue Growth 2017-2022 ($ Millions)

Figure 78. Manufacturing Cost Structure Analysis of Cancer Ablation Devices in 2021

Figure 79. Manufacturing Process Analysis of Cancer Ablation Devices

Figure 80. Industry Chain Structure of Cancer Ablation Devices

Figure 81. Channels of Distribution

Figure 82. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450